Mantle cell lymphoma (MCL) is an uncommon subtype of non-Hodgkin lymphoma occurring
in adults and elderly people with a peculiar male predominance. Genetically, it is …

Mantle cell lymphoma (MCL) accounts for approx-imately 6% of all non-Hodgkin's
lymphomas1 and is characterized by the over-expression of cyclin D1 with cell cycle …

Mantle cell lymphoma (MCL) is an aggressive B-cell neoplasm with a median survival of the
patients of 3--5 years. 1 This aggressive behavior has been related to its genetic and …

Mantle cell lymphoma (MCL) is considered a distinct type of B-cell lymphoma genetically
characterized by the t (11; 14) translocation and cyclin D1 overexpression. There is also a …

While it is quite unusual for totally new types of cancer to develop, it is not unusual for new
and distinct forms of cancer to be recognized among what were previously thought to be well …

Mantle cell lymphoma is included in the World Health Organization classification as distinct
lymphoma subtype characterized by the t (11; 14)(q13; q32) translocation, which results in …

Mantle cell lymphoma (MCL) is a less frequent subtype of lymphoid malignancies and
represents 6%–9% of malignant lymphoma in Western Europe. The annual incidence of this …

Mantle cell lymphoma (MCL) is nowadays recog-nized as a spectrum of diseases,
characterized by significantly different treatment responses and outcomes. Some predictors …

Mantle cell lymphoma (MCL) is one of the lymphomas with the worse prognosis (median
survival 3–5years) as it has an aggressive evolution and at the same time is incurable …

The unifying concept defining mantle-cell lymphoma (MCL) as at (11; 14)-containing
lymphoma driven by cyclin D1 dates to the early 1990s. 1 With median survival of 3 to 5 …